Insiders Are Buying Immunomedics, Inc. (NASDAQ:IMMU)

Lester Mason
December 7, 2017

Its down 0.05, from 1.46 in 2017Q1. The stock grabbed 34 new institutional investments totaling 14,925,449 shares while 14 institutional investors sold out their entire positions totaling 5,468,744 shares. 30 funds opened positions while 46 raised stakes. State Board Of Administration Of Florida Retirement stated it has 0% in Immunomedics, Inc.

Previously Immunomedics Inc (NASDAQ:IMMU) reported $-0.97 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.11 by $-0.86. Hanseatic Mgmt Svcs reported 158 shares. Prudential Fincl holds 10,613 shares. Barclays Public Limited Co has 74,145 shares. Credit Suisse Ag has 0% invested in Immunomedics, Inc. (NASDAQ:IMMU). 5,000 are held by Tci Wealth Advsr. (NASDAQ:IMMU) has gone stronger by 175.46%. Jennison Ltd Liability owns 1.08 million shares for 0.01% of their portfolio. Voya Invest Llc has invested 0% in Immunomedics, Inc. Alliancebernstein LP owns 178,198 shares. Access it here: 000119312517362869. Raymond James Financial Services Advisors Inc. lifted its holdings in Immunomedics by 11.4% in the 2nd quarter. "Is Soaring Today" on December 06, 2017.

Several analysts have released their opinion on Immunomedics, Inc. There were 19 that closed positions and 23 reduced them. Further, Orbimed Advisors Llc reported stake worth 0.06% of its portfolio.

The company's stock is now moving with a +ve distance from the 200 day SMA of approximately 3.2%, and has a solid year to date (YTD) performance of 145.23% which means that the stock is constantly adding to its value from the previous fiscal year end price. Immunomedics Inc is 1.70% of its portfolio. (NASDAQ:IMMU) has been trading recently. The stock increased 13.00% or $1.18 during the last trading session, reaching $10.21.

Immunomedics Inc. has its outstanding Shares of 147.54 Million.


Match Group, Inc. (NASDAQ:MTCH) has a market cap of $7.65 billion and over the last 12 months, MTCH has risen by 61.33%. It has outperformed by 59.56% the S&P500. Following the completion of the transaction, the director now directly owns 99,178 shares in the company, valued at approximately $1,179,226.42. It also develops products for the treatment of cancer and autoimmune diseases, including epratuzumab, anti-CD22 antibody; veltuzumab, anti-CD20 antibody; milatuzumab, anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody.

Immunomedics Inc (NASDAQ:IMMU) 52-week high price stands at $14.48 and low price stands at $3.16, its price distance from 52-week high is -37.58% while its distance from 52-week low price is 185.92%. Therefore 67% are positive. There are brokerage firms with lower targets than the average, including one setting a price target of $14. Immunomedics had 13 analyst reports since July 29, 2015 according to SRatingsIntel. To calculate this rate, I've appended a line of best fit through the forecasted earnings by market analysts. Jefferies maintained Immunomedics, Inc. (NASDAQ:IMMU) has "Buy" rating given on Monday, October 9 by Jefferies. As per Tuesday, March 15, the company rating was maintained by Jefferies. The rating was upgraded by Jefferies on Friday, May 6 to "Buy". The firm has "Buy" rating by Cowen & Co given on Monday, July 24. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company's stock. The company was maintained on Friday, June 9 by Jefferies. Jefferies maintained it with "Buy" rating and $11.0 target in Thursday, August 17 report. The rating was downgraded by Wells Fargo on Friday, December 4 to "Market Perform". On Thursday, October 6 the stock rating was reinitiated by Jefferies with "Buy".

Immunomedics, Inc is a clinical-stage biopharmaceutical company.

Immunomedics, Inc. (NASDAQ:IMMU) stands -20.58% away from its 50-day simple moving average and also 3.15% away from the 200-day average. More interesting news about Immunomedics, Inc. (NASDAQ:IMMU). Css Ltd Llc Il has invested 0% in Immunomedics, Inc. "Jumped Higher Today" on November 10, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER